PRALSETINIB

Clinical trials for PRALSETINIB explained in plain language.

Never miss a new study

Get alerted when new PRALSETINIB trials appear

Sign up with your email to follow new studies for PRALSETINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a simple pill prevent a common side effect of targeted lung cancer therapy?

Disease control Not yet recruiting

This study looks at whether taking leucogen (a drug that raises white blood cell counts) from the start can prevent low white blood cells in people with RET fusion-positive non-small cell lung cancer who are taking pralsetinib. About 25 people who have not had prior treatment wil…

Matched conditions: PRALSETINIB

Phase: NA • Sponsor: Fudan University • Aim: Disease control

Last updated Jun 27, 2026 09:05 UTC

PRALSETINIB

Get alerted when new PRALSETINIB trials appear

Can a simple pill prevent a common side effect of targeted lung cancer therapy?